在接受他汀类药物治疗的患者中，低密度脂蛋白（LDL）、非高密度脂蛋白（non-HDL）和载脂蛋白B（apoB）胆固醇生物标志物与心血管事件风险增加相关。 - Suppr

Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events.

作者信息

Sniderman Allan David, Thanassoulis George

机构信息

Department of Medicine/Cardiology, McGill University, Montreal, Quebec, Canada.

出版信息

Evid Based Med. 2013 Apr;18(2):73-4. doi: 10.1136/eb-2012-100787. Epub 2012 Aug 14.

DOI:10.1136/eb-2012-100787

PMID:22893654

Abstract

摘要

相似文献

Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events.

Evid Based Med. 2013 Apr;18(2):73-4. doi: 10.1136/eb-2012-100787. Epub 2012 Aug 14.

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.

JAMA. 2012 Mar 28;307(12):1302-9. doi: 10.1001/jama.2012.366.

Lipid parameters and cardiovascular events in patients taking statins.

JAMA. 2012 Jul 11;308(2):131-2; author reply 132-3. doi: 10.1001/jama.2012.6614.

Lipid parameters and cardiovascular events in patients taking statins.

JAMA. 2012 Jul 11;308(2):132; author reply 132-3. doi: 10.1001/jama.2012.6616.

Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.

JAMA. 2017 Sep 12;318(10):947-956. doi: 10.1001/jama.2017.11467.

New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.

Clin Ther. 2013 Aug;35(8):1082-98. doi: 10.1016/j.clinthera.2013.06.019. Epub 2013 Aug 8.

Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients.

J Am Coll Cardiol. 2021 Mar 23;77(11):1439-1450. doi: 10.1016/j.jacc.2021.01.027.

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.

Lancet. 2003 Mar 1;361(9359):777-80. doi: 10.1016/s0140-6736(03)12663-3.

ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients.

Curr Med Res Opin. 2008 Feb;24(2):359-64. doi: 10.1185/030079907x253906.

Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials.

Am J Cardiol. 2012 Nov 15;110(10):1468-76. doi: 10.1016/j.amjcard.2012.07.007. Epub 2012 Aug 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events.

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events.

作者信息

机构信息

出版信息

相似文献